Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malva sylvestris cream for episiotomy pain
IRCT20100130003226N20Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of mallow extract in episiotomy pain, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Episiotomy pain intensity. Started Apr 2023; status: completed.
02
Drugs
mallow extract
03
Conditions
episiotomy pain
Beyond the preview
Go deeper on IRCT20100130003226N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100130003226N20.